Diagnosis of nontuberculous mycobacterial disease in the era of surveillance chest CT scans
The radiologic surveillance of smokers with low-dose CT scan has led to a significant surge of radiologic incidental findings, including the detection of early stages of pulmonary infections including nontuberculous mycobacteria (NTM). This causes a state of overdiagnosis and potential overtreatment of NTM lung disease. Here we propose a new approach to NTM pulmonary disease in the era of increased CT scanning.
KeywordsNontuberculous MAC Mycobacterial Lung disease
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Compliance with ethical standards
Conflict of interest
All authors report no conflict of interest. Guarantor of the paper: Mehdi Mirsaeidi MD, MPH.
- 1.Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367–416. https://doi.org/10.1164/rccm.200604-571ST.CrossRefPubMedGoogle Scholar
- 4.Winthrop KL, McNelley E, Kendall B, Marshall-Olson A, Morris C, Cassidy M, et al. Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. Am J Respir Crit Care Med. 2010;182:977–82. https://doi.org/10.1164/rccm.201003-0503OC.CrossRefPubMedGoogle Scholar
- 5.Johnson MM, Odell JA. Nontuberculous mycobacterial pulmonary infections. J Thorac Dis. 2014;6:210–20. https://doi.org/10.3978/j.issn.2072-1439.2013.12.24.CrossRefPubMedPubMedCentralGoogle Scholar